MTOR antibody (AA 1720-2020)
Quick Overview for MTOR antibody (AA 1720-2020) (ABIN2308359)
Target
See all MTOR (mTOR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1720-2020
-
Cross-Reactivity
- Human, Mouse (Murine)
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu Mo
-
Characteristics
- mTOR (mTAb1, Mammalian Target of Rapamycin, FRAP, RAFT)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogen
- Recombinant corresponding to aa1720-2020 of human TOR expressed in E. coli (NP_004949).
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 200 μL sterile PBS.
-
Buffer
- Supplied as a lyophilized powder from a 0.2um filtered solution in PBS with 5 % trehalose.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- MTOR (mTOR) (Mechanistic Target of Rapamycin (serine/threonine Kinase) (mTOR))
-
Alternative Name
- mTOR
-
Pathways
- PI3K-Akt Signaling, RTK Signaling, AMPK Signaling, Interferon-gamma Pathway, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Actin Filament Polymerization, Regulation of Muscle Cell Differentiation, Regulation of Cell Size, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Autophagy, CXCR4-mediated Signaling Events, BCR Signaling, Warburg Effect
Target
-